340B Program: Indie Art’s Unseen Lifeline in 2026
How does the federal 340B drug program, supporting 2,700+ hospitals, indirectly fund indie art? See why its future matters for local culture.
How does the federal 340B drug program, supporting 2,700+ hospitals, indirectly fund indie art? See why its future matters for local culture.
Can sci-fi predict CRISPR's ethical dilemmas? See how 2026's speculative fiction warns policymakers about gene editing's future. What to watch next.
Indie comics fight the $300 billion drug adherence crisis. See how visual stories explain complex health info, boosting patient engagement.
Why is the 340B drug discount program struggling like indie film funding? Learn how policy changes impact 340B entities & patient care.
How did podcasts like Pharma Uncovered expose drug pricing in 2026? Learn why niche audio programs now drive transparency in pharmaceutical supply chains.
Indie comic creators face shrinking profits by 15% due to rising costs. Learn why this squeeze matters and what strategies, like crowdfunding, can help.
Why are some 340B hospitals funding niche film projects? Learn how drug discounts may be diverted, raising questions about patient care.
Indie films reveal how pharma giants influence policy and pricing. See how Merck and others shape healthcare, impacting you.
Biotech patents favor big corporations, stifling indie innovation. Learn why this system costs hundreds of thousands and what's next.
Beyond hospital discounts: See how 340B impacts niche drug makers & patient access. What to watch for 2026.